TrialPloS one2018

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Kateřina Kuželová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.